Literature DB >> 18664473

Prostate-specific antigen in vaginal fluid after exposure to known amounts of semen and after condom use: comparison of self-collected and nurse-collected samples.

Luis Bahamondes1, Juan Diaz, Nadia Maria Marchi, Sara Castro, Marina Villarroel, Maurizio Macaluso.   

Abstract

BACKGROUND: Prostate-specific antigen (PSA) in vaginal fluid indicates exposure to semen, and was used to assess condom effectiveness, although validity and reliability have not been fully evaluated. Our objective was to compare PSA in self-collected samples with samples collected by a nurse.
METHODS: We conducted two studies, each with 100 women aged 18-48 years. In the first, a nurse exposed each participant to her partner's semen (10, 100 and 1000 microl), and nurse and participant collected samples. In the second, each participant sampled before and after using two male condoms (MC) and two female condoms (FC); a nurse collected another sample afterwards.
RESULTS: PSA concentration increased with semen exposure, but was lower in nurse-collected samples. Both procedures were sensitive, almost 100% after exposure to 100-1000 microl of semen. PSA detection rates with MC and FC were 13% and 28% in self-collected samples, 8% and 9% in nurse-collected samples. Concordance between sample types was 93% with the MC (95% CI: 89%; 96%), 78% with the FC (95% CI: 72%; 84%). PSA decay between sampling times may explain higher values in self-collected samples.
CONCLUSIONS: PSA is a highly sensitive surrogate endpoint for condom effectiveness studies. Self-collected and nurse-collected samples are equivalent, but sample collection timing is critical.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664473     DOI: 10.1093/humrep/den283

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  15 in total

1.  Prostate-specific antigen concentration in vaginal fluid after exposure to semen.

Authors:  Andrzej Kulczycki; Ilene Brill; Margaret Christine Snead; Maurizio Macaluso
Journal:  Contraception       Date:  2017-07-12       Impact factor: 3.375

2.  The use of biomarkers of semen exposure in sexual and reproductive health studies.

Authors:  Margaret Christine Snead; Carolyn M Black; Athena P Kourtis
Journal:  J Womens Health (Larchmt)       Date:  2014-09-30       Impact factor: 2.681

3.  Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance.

Authors:  Terri Walsh; Lee Warner; Maurizio Macaluso; Ron Frezieres; Margaret Snead; Brian Wraxall
Journal:  Contraception       Date:  2012-03-02       Impact factor: 3.375

4.  Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay.

Authors:  Margaret C Snead; Johan H Melendez; Athena P Kourtis; Dorothy M Chaney; Teresa M Brown; Carolyn M Black; Christine K Mauck; Jill L Schwartz; Jonathan M Zenilman; Denise J Jamieson; Maurizio Macaluso; Gustavo F Doncel
Journal:  Contraception       Date:  2013-11-12       Impact factor: 3.375

5.  Recent Biomarker-Confirmed Unprotected Vaginal Sex, But Not Self-reported Unprotected Sex, Is Associated With Recurrent Bacterial Vaginosis.

Authors:  Abigail Norris Turner; Patricia Carr Reese; Margaret Christine Snead; Karen Fields; Melissa Ervin; Athena P Kourtis; Mark A Klebanoff; Maria F Gallo
Journal:  Sex Transm Dis       Date:  2016-03       Impact factor: 2.830

6.  Y chromosome and HIV DNA detection in vaginal swabs as biomarkers of semen and HIV exposure in women.

Authors:  Kerri J Penrose; Barbra A Richardson; Guillaume Besson; Charlene S Dezzutti; Betsy C Herold; Salim S Abdool Karim; John W Mellors; Urvi M Parikh
Journal:  Sex Transm Dis       Date:  2014-11       Impact factor: 2.830

7.  Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception.

Authors:  Renee Heffron; Urvi M Parikh; Kerri J Penrose; Nelly Mugo; Deborah Donnell; Connie Celum; John W Mellors; Jared M Baeten
Journal:  AIDS Behav       Date:  2017-07

8.  Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: implications for qualitative research.

Authors:  Marcia M Hobbs; Markus J Steiner; Kimberly D Rich; Maria F Gallo; Anadil Alam; Motiur Rahman; Prema Menezes; Tsungai Chipato; Lee Warner; Maurizio Macaluso
Journal:  Sex Transm Dis       Date:  2009-08       Impact factor: 2.830

9.  Assessment of the vaginal residence time of biomarkers of semen exposure.

Authors:  Andrea Thurman; Terry Jacot; Johan Melendez; Thomas Kimble; Margaret Snead; Roxanne Jamshidi; Angie Wheeless; David F Archer; Gustavo F Doncel; Christine Mauck
Journal:  Contraception       Date:  2016-05-31       Impact factor: 3.375

10.  Comparison of self-reported female condom failure and biomarker-confirmed semen exposure.

Authors:  Terri L Walsh; Margaret C Snead; Breione J St Claire; Jill L Schwartz; Christine K Mauck; Ron G Frezieres; Diana L Blithe; David F Archer; Kurt T Barnhart; Jeffrey T Jensen; Anita L Nelson; Michael A Thomas; Livia S Wan; Mark A Weaver
Journal:  Contraception       Date:  2019-08-02       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.